The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
3 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,015
Mason, D. R., Beck, P. L., & Muruve, D. A. (2011) · Journal of Innate Immunity · doi:10.1159/000334247 · Cited by 106
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 109
Microglia in Alzheimer’s disease: A target for immunotherapy
Wang, S., & Colonna, M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0818-319r · Cited by 106
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alsayegh, A. A., Hakami, Z. H., Khamjan, N. A., Saad, H. M., Batiha, G. E., & WAARD, M. M. D. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03817-4 · Cited by 106
Liu, L., & Chan, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.016 · Cited by 108
Conforti‐Andreoni, C., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.81 · Cited by 109
Hook, G., Jacobsen, J. S., Grabstein, K. H., Kindy, M. S., & HOOK, V. Y. H. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00178 · Cited by 110
Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model
Erlich, Z., Shlomovitz, I., Edry‐Botzer, L., Cohen, H., Frank, D. O., Wang, H., Lew, A. M., Lawlor, K. E., Zhan, Y., Vince, J. E., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0313-5 · Cited by 100
Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation
Deng, W., Yang, Z., Hu, Y., Ou, Y., Hu, W., & Sun, P. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.007 · Cited by 106
The inflammatory status of the elderly: The intestinal contribution
Schiffrin, E. J., Morley, J. E., Donnet‐Hughes, A., & Guigoz, Y. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.07.011 · Cited by 103
Microglial Activation in Alzheimers Disease
Schlachetzki, J. C. M., & Hüll, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 105
Xie, Q., SHEN, W.-W., Zhong, J., Huang, C., Zhang, L., & Li, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1755 · Cited by 104
Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia
Kim, J.-Y., Paton, J. C., Briles, D. E., Rhee, D., & Pyo, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6592 · Cited by 103
The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian, A., Engen, P. A., Bonvegna, S., & Cilia, R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 108
Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
de Oliveira, J., Kucharska, E., Garcez, M. L., Rodrigues, M. S., Quevedo, J., Moreno‐González, I., & Budni, J. (2021) · Cells · doi:10.3390/cells10102581 · Cited by 110
Innate Defense against Fungal PathogensPreprint
Drummond, R. A., Gaffen, S. L., Hise, A. G., & Brown, G. D. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019620 · Cited by 102
Zou, J., Kawai, T., Tsuchida, T., Kozaki, T., Tanaka, H., Shin, K.-S., Kumar, H., & Akira, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.007 · Cited by 103
Regulation of brain microglia by female gonadal steroids
Habib, P., & Beyer, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.018 · Cited by 118
NLRP3 Inflammasome: Activation and Regulation in Age‐Related Macular Degeneration
Gao, J., Liu, R. T., Cao, S., Cui, J. Z., Wang, A., To, E. C., & Matsubara, J. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/690243 · Cited by 105
Manne, S., Kondru, N. C., Hepker, M., Jin, H., Anantharam, V., Lewis, M. M., Huang, X., Kanthasamy, A., & Kanthasamy, A. G. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09835-4 · Cited by 101
Terada, K., Yamada, J., Hayashi, Y., Wu, Z., Uchiyama, Y., Peters, C., & Nakanishi, H. (2009) · Glia · doi:10.1002/glia.20906 · Cited by 102
Advances in Nod-like receptors (NLR) biology
Barbé, F., Douglas, T., & Saleh, M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.001 · Cited by 106
NLRs, inflammasomes, and viral infection
Jacobs, S. R., & Damania, B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312132 · Cited by 104
Koka, S., Xia, M., Chen, Y., Bhat, O. M., Yuan, X., Boini, K. M., & Li, P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.004 · Cited by 101
Ketelut-Carneiro, N., Silva, G. K., Rocha, F. A., Milanezi, C. M., Neto, F. F. C., Zamboni, D. S., & Silva, J. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402321 · Cited by 100
Greenfield, E. M., Beidelschies, M. A., Tatro, J. M., Goldberg, V. M., & Hise, A. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136895 · Cited by 103
The Role of Potassium in Inflammasome Activation by Bacteria
Arlehamn, C. S. L., Pétrilli, V., Groß, O., Tschopp, J., & Evans, T. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067298 · Cited by 101
Overview of Traumatic Brain Injury: An Immunological Context
Nizamutdinov, D., & Shapiro, L. A. (2017) · Brain Sciences · doi:10.3390/brainsci7010011 · Cited by 104
Ren, P., Chen, J., Li, B., Zhang, M., Yang, B., Guo, X., Chen, Z., Cheng, H., Wang, P., Wang, S.-B., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3050971 · Cited by 101
Liu, H., Zhan, X., Xu, G., Wang, Z., Li, R., Wang, Y., Qin, Q., Shi, W., Hou, X., Yang, R., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105384 · Cited by 101
Hofbauer, D., Mougiakakos, D., Broggini, L., Zaiss, M., Büttner-Herold, M., Bach, C., Spriewald, B., Neumann, F., Bisht, S., Nolting, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.002 · Cited by 100
Guan, L., Mao, Z., Yang, S., Wu, G., Chen, Y., Yin, L., Qi, Y., Han, L., & Xu, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113248 · Cited by 101
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Javanmehr, N., Saleki, K., Alijanizadeh, P., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02637-1 · Cited by 106
Nour, A. M., Reichelt, M., Ku, C., Ho, M.-Y., Heineman, T. C., & Arvin, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210575 · Cited by 100
Microglial Cathepsin B Contributes to the Initiation of Peripheral Inflammation-Induced Chronic Pain
Sun, L., Wu, Z., Hayashi, Y., Peters, C., Tsuda, M., Inoue, K., & Nakanishi, H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0677-12.2012 · Cited by 100
Multiple inflammasome complexes are activated in autistic spectrum disorders
Saresella, M., Piancone, F., Marventano, I., Zoppis, M., Hernis, A., Zanette, M., Trabattoni, D., Chiappedi, M. A., Ghezzo, A., Canevini, M. P., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.009 · Cited by 106
Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection
Qi, X., Man, S. M., Malireddi, R. K. S., Karki, R., Lupfer, C. R., Gurung, P., Neale, G. A. M., Guy, C. S., Lamkanfi, M., & Kanneganti, T. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151938 · Cited by 99
The emerging roles of inflammasome‐dependent cytokines in cancer development
Gorp, H. V., & Lamkanfi, M. (2019) · EMBO Reports · doi:10.15252/embr.201847575 · Cited by 101
TRPM2 Channel-Mediated ROS-Sensitive Ca2+ Signaling Mechanisms in Immune Cells
Mortadza, S. A. S., Wang, L., Li, D., & Jiang, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00407 · Cited by 100
Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice
Babcock, A. A., Ilkjær, L., Clausen, B. H., Villadsen, B., Dissing-Olesen, L., Bendixen, A. T. M., Lyck, L., Lambertsen, K. L., & Finsen, B. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.006 · Cited by 107
Ren, J., Wu, X., Jiang, R. M., Hao, D.-P., & Liu, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.012 · Cited by 97
Flores, J., Noël, A., Foveau, B., Beauchet, O., & LeBlanc, A. C. (2020) · Nature Communications · doi:10.1038/s41467-020-18405-9 · Cited by 103
Liao, P., Chao, L. K., Chou, J., Dong, W.-C., Lin, C.-N., Lin, C.-Y., Chen, A., Ka, S., Ho, C., & Hua, K. (2012) · Inflammation Research · doi:10.1007/s00011-012-0555-2 · Cited by 97
Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97
Neuroinflammation, immune system and Alzheimer disease: searching for the missing link
Guerriero, F., Sgarlata, C. S., Francis, M., Maurizi, N., Faragli, A., Perna, S., Rondanelli, M., Rollone, M., & Ricevuti, G. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0637-z · Cited by 98
Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation
de Oliveira, L. G., Angelo, Y. D. S., Iglesias, A. H., & Peron, J. P. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624919 · Cited by 100
Ghanbari, M., Maragheh, S. M., Aghazadeh, A., Mehrjuyan, S. R., Hussen, B. M., Shadbad, M. A., Dastmalchi, N., & Safaralizadeh, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107765 · Cited by 101
Zhao, N., Li, C.-C., Di, B., & Xu, L.-L. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102515 · Cited by 103
Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure
Reichold, M., Klootwijk, E. D., Reinders, J., Otto, E. A., Milani, M., Broeker, C., Laing, C. M., Wiesner, J., Devi, S., Zhou, W., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017111179 · Cited by 97
Couturier, J., Stancu, I., Schakman, O., Pierrot, N., Huaux, F., Kienlen‐Campard, P., Dewachter, I., & Octave, J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0477-y · Cited by 95
Naeem, A., Prakash, R., Kumari, N., Ali Khan, M., Quaiyoom Khan, A., Uddin, S., Verma, S., AB Robertson, A., Boltze, J., & Shadab Raza, S. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.11.031 · Cited by 96
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Wang, S., Zhao, X., Yang, S., Chen, B., & Shi, J. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.10.012 · Cited by 95
Cerqueira, D. M., Gomes, M. T. R., Silva, A. L. N., Rungue, M., Assis, N. R. G., Guimarães, E. S., Morais, S. B., Brož, P., Zamboni, D. S., & Oliveira, S. C. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007519 · Cited by 98
Inflammasome Activation: A Keystone of Proinflammatory Response in Obstructive Sleep Apnea
Díaz‐García, E., García-Tovar, S., Alfaro, E., Oriol, A. J., Casitas, R., Sánchez-Sánchez, B., Zamarrón, E., Fernández-Lahera, J., López‐Collazo, E., Cubillos-Zapata, C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202106-1445oc · Cited by 96
Hook, G., Reinheckel, T., Ni, J., Wu, Z., Kindy, M. S., Peters, C., & HOOK, V. Y. H. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000527 · Cited by 98
Self-citationChemical probing reveals insights into the signaling mechanism of inflammasome activation
Gong, Y., Wang, X., Wang, J., Yang, Z., Li, S., Yang, J., Liu, L., Lei, X., & Shao, F. (2010) · Cell Research · doi:10.1038/cr.2010.135 · Cited by 96
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
Taylor, J. M., Moore, Z., Minter, M. R., & Crack, P. J. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1745-4 · Cited by 94
Is Alzheimer’s disease an inflammasomopathy?
Pereira, C., Santos, A. E., Moreira, P. I., Pereira, A. C., Sousa, F. J., Cardoso, S. M., & Cruz, M. T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100966 · Cited by 95
Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
Sarkar, S., Dammer, E. B., Malovic, E., Olsen, A. L., Raza, S. A., Gao, T., Xiao, H., Oliver, D. L., Duong, D. M., Joers, V. L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00033 · Cited by 93
Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain
Chen, Y., Li, Y., Guo, L., Hong, J. Y., Zhao, W., Hu, X., Chang, C., Liu, W., & Xiong, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.626502 · Cited by 94
An, Y. W., Jhang, K. A., Woo, S., Kang, J. L., & Chong, Y. H. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.016 · Cited by 95
Pattern Recognition Receptors in Cancer Progression and Metastasis
Pandey, S., Singh, S. P., Anang, V., Bhatt, A. N., Natarajan, K., & Dwarakanath, B. S. R. (2015) · Cancer Growth and Metastasis · doi:10.4137/cgm.s24314 · Cited by 95
A Double-edged Sword: Uric Acid and Neurological Disorders
Luo, X. L. J. J. (2013) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000109 · Cited by 94
Inflammasome-mediated innate immunity in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900439 · Cited by 93
Morishige, T., Yoshioka, Y., Tanabe, A., Yao, X., Tsunoda, S., Tsutsumi, Y. M., Mukai, Y., Okada, N., & Nakagawa, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.178 · Cited by 94
Inflammasome activation and Th17 responses
Deng, J. P., Yu, X., & Wang, P. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 94
Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis
McElvaney, O. J., Zasłona, Z., Becker-Flegler, K. A., Pålsson‐McDermott, E. M., Boland, F., Gunaratnam, C., Gulbins, E., O'Neill, L. A. J., Reeves, E. P., & McElvaney, N. G. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201905-1013oc · Cited by 97
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 97
Harrison, D., Billinton, A., Bock, M. G., Doedens, J. R., Gabel, C. A., Holloway, M. K., Porter, R. A., Reader, V., Scanlon, J., Schooley, K., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01398 · Cited by 93
NLRP3 Inflammasome Activation Mediates Zika Virus–Associated Inflammation
He, Z., Chen, J., Zhu, X., An, S., Dong, X., Yu, J., Zhang, S., Wu, Y., Li, G., Zhang, Y. L., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy129 · Cited by 93
Ghezzi, P., Floridi, L., Boraschi, D., Cuadrado, A., Manda, G., Levic, S., D’Acquisto, F., Hamilton, A., Athersuch, T. J., & Selley, L. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7147 · Cited by 95
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity
Marzeda, A. M., & Midwood, K. S. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418757443 · Cited by 94
Pellegrini, C., D’Antongiovanni, V., Miraglia, F., Rota, L., Benvenuti, L., Salvo, C. D., Testa, G., Capsoni, S., Carta, G., Antonioli, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00263-x · Cited by 96
Jung, E. S., Suh, K., Han, J., Kim, H., Kang, H., Choi, W., & Mook‐Jung, I. (2022) · Aging Cell · doi:10.1111/acel.13623 · Cited by 97
Endocytosis of Particle Formulations by Macrophages and Its Application to Clinical Treatment
Hirota, K., & Ter, H. (2012) · InTech eBooks · doi:10.5772/45820 · Cited by 92
Hafner‐Bratkovič, I., Benčina, M., Fitzgerald, K. A., Golenbock, D. T., & Jerala, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1140-0 · Cited by 92
Self-citationInoue, M., & Shinohara, M. L. (2013) · Immunology · doi:10.1111/imm.12081 · Cited by 91
Nishimori, J. H., Newman, T., Oppong, G. O., Rapsinski, G. J., Yen, J.-H. J., Biesecker, S. G., Wilson, R. P., Butler, B. P., Winter, M. G., Tsolis, R. M., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00911-12 · Cited by 96
Zhang, Y., Li, X., Pitzer, A. L., Chen, Y., Wang, L., & Li, P. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5978 · Cited by 90
Role of pancreatic β ‐cell death and inflammation in diabetes
Quan, W., Jo, E., & Lee, M. ‐. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12153 · Cited by 92
NLR-Dependent Regulation of Inflammation in Multiple Sclerosis
Gharagozloo, M., Gris, K. V., Mahvelati, T. M., Amrani, A., Lukens, J. R., & Gris, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02012 · Cited by 98
Mechanosensitive TRPV4 is required for crystal-induced inflammation
Lan, Z., Chen, L., Feng, J., Xie, Z., Liu, Z., Wang, F., Liu, P., Yue, X., Du, L., Zhao, Y., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220295 · Cited by 96
Boini, K. M., Xia, M., Abais, J. M., Li, G., Pitzer, A. L., Gehr, T. W. B., Zhang, Y., & Li, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.033 · Cited by 91
Sphingosine regulates the NLRP3‐inflammasome and IL‐1β release from macrophages
Luheshi, N., Giles, J. A., López‐Castejón, G., & Brough, D. (2011) · European Journal of Immunology · doi:10.1002/eji.201142079 · Cited by 91
Lysosomes: regulators of autophagy in the retinal pigmented epithelium
Sinha, D., Valapala, M., Shang, P., Hose, S., Grebe, R., Lutty, G. A., Zigler, J. S., Kaarniranta, K., & Handa, J. T. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.018 · Cited by 88
CA-074Me Protection against Anthrax Lethal Toxin
Newman, Z. L., Leppla, S. H., & Moayeri, M. (2009) · Infection and Immunity · doi:10.1128/iai.00730-09 · Cited by 91
Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury
Lee, S. W., Gajavelli, S., Spurlock, M. S., Andreoni, C. B., Vaccari, J. P. D. R., Bullock, M. R., Keane, R. W., & Dietrich, W. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5530 · Cited by 89
Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
Gan, C., Cai, Q., Tang, C., & Gao, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896473 · Cited by 94
Dubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 101
Silva, G. K., Sesti‐Costa, R., Silveira, T. N., Caetano, B. C., Horta, C. V., Gutierrez, F. R. S., Guedes, P. M. D. M., Andrade, W. A., Niz, M. D., Gazzinelli, R. T., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203293 · Cited by 89
Activation of mixed glia by Aβ-specific Th1 and Th17 cells and its regulation by Th2 cells
McQuillan, K., Lynch, M. A., & Mills, K. H. G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.003 · Cited by 90
Watanabe, Y., Nagai, Y., & Takatsu, K. (2013) · Nutrients · doi:10.3390/nu5093757 · Cited by 92
Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice
Yu, C., Moecking, J., Geyer, M., & Masters, S. L. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.07.012 · Cited by 91
Specific inflammasomes in complex diseases
Masters, S. L. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.006 · Cited by 97
Interleukin-18, From Neuroinflammation to Alzheimers Disease
Bossù, P., Ciaramella, A., Salani, F., Vanni, D., Palladino, I., Caltagirone, C., & Scapigliati, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210794519147 · Cited by 89
Martinvalet, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0237-7 · Cited by 94
Chae, J. J., Park, Y. H., Park, C., Hwang, I., Hoffmann, P., Kehrl, J. H., Aksentijevich, I., & Kastner, D. L. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38961 · Cited by 89
Wu, Z., Sun, L., Hashioka, S., Yu, S., Schwab, C., Okada, R., Hayashi, Y., McGeer, P. L., & Nakanishi, H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.018 · Cited by 91
The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
Sebastian-Valverde, M., & Pasinetti, G. M. (2020) · Cells · doi:10.3390/cells9061552 · Cited by 90
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
